Molecule Docking Software Licensed to Inhibox Ltd
Despite considerable advances over recent decades, cancer, and many other diseases remain poorly treated. Many therapeutic regimes frequently subject the sufferer to severe side-effects, and resistance often develops to therapies that are initially effective. For many illnesses, the life-expectance upon diagnosis is depressingly short. There is an urgent need for new, more effective, therapeutic options.